Nintedanib impurity 20

C14H22N4O

262.36

N-(4-氨基苯基)-N,4-二甲基-1-哌嗪乙酰胺; N-(4-氨基苯基)-N,4-二甲基-1-哌嗪乙酰胺(尼达尼布中间体); N-(4-氨基苯基)-N,4-二甲基-1-哌嗪乙酰胺/BIBF1120; N-(4-氨基苯基)-N,4-二甲基-1-哌嗪乙酰胺(尼达尼布中间体,BIBF-1120中间体); N-(4-氨基苯基)-N-甲基-2-(4-甲基哌嗪-1-基)乙酰胺; 尼达尼布中间体; 尼达尼布杂质E; N-(4-氨基苯基)-N,4-二甲基;

N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide; N-(4-Aminophenyl)-N,4-dimethyl-1-piperazineacetamide; N-[(4-methyl-piperazin-1-yl)methylcarbonyl]-N-methyl-p-phenylendiamine; -N-methyl-2-(4-methylpiperazin-1-yl); Nintedanib Intermediate 2;